EP Patent

EP2407157A1 — Lipid bilayer carrier for drugs or imaging agents

Assigned to Koninklijke Philips NV · Expires 2012-01-18 · 14y expired

What this patent protects

Disclosed are carriers for drugs and/or MR imaging agents having a lipid bilayer shell comprising a phospholipid having two terminal alkyl chains, one being a short chain having a chain length of at most fourteen carbon atoms, the other being a long chain having a chain length of…

USPTO Abstract

Disclosed are carriers for drugs and/or MR imaging agents having a lipid bilayer shell comprising a phospholipid having two terminal alkyl chains, one being a short chain having a chain length of at most fourteen carbon atoms, the other being a long chain having a chain length of at least fifteen carbon atoms. The mixed long/short chain phospholipids serve to tune the release properties of the carrier. Preferred phospholipids are phosphatidylcho lines.

Drugs covered by this patent

Patent Metadata

Patent number
EP2407157A1
Jurisdiction
EP
Classification
—
Expires
2012-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Koninklijke Philips NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.